These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3979577)

  • 1. Hot flashes in postmenopausal women ameliorated by danazol.
    Foster GV; Zacur HA; Rock JA
    Fertil Steril; 1985 Mar; 43(3):401-4. PubMed ID: 3979577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaginal, endometrial, and reproductive hormone findings: randomized, placebo-controlled trial of black cohosh, multibotanical herbs, and dietary soy for vasomotor symptoms: the Herbal Alternatives for Menopause (HALT) Study.
    Reed SD; Newton KM; LaCroix AZ; Grothaus LC; Grieco VS; Ehrlich K
    Menopause; 2008; 15(1):51-8. PubMed ID: 18257142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The hormonal effect of danazol in women with regular menstrual cycles and in those with ovarian deficiency].
    Bertaglia MG; Miragoli A; Dorato F; Nencioni T
    Ann Ostet Ginecol Med Perinat; 1980; 101(3):173-80. PubMed ID: 6779692
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical investigation of RAD1901, a novel estrogen receptor ligand, for the treatment of postmenopausal vasomotor symptoms: a phase 2 randomized, placebo-controlled, double-blind, dose-ranging, proof-of-concept trial.
    Hattersley G; Harris AG; Simon JA; Constantine GD
    Menopause; 2017 Jan; 24(1):92-99. PubMed ID: 27575546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Danazol on pituitary gonadotrophins in post-menopausal women.
    Fraser IS; Thorburn GD
    Aust N Z J Obstet Gynaecol; 1978 Nov; 18(4):247-9. PubMed ID: 284768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tibolone for the treatment of moderate to severe vasomotor symptoms and genital atrophy in postmenopausal women: a multicenter, randomized, double-blind, placebo-controlled study.
    Swanson SG; Drosman S; Helmond FA; Stathopoulos VM
    Menopause; 2006; 13(6):917-25. PubMed ID: 17006377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary results on clinical and endocrine studies in the treatment of menorrhagia with danazol.
    Chimbira TH; Anderson AB; Cope E; Turnbull AC
    Postgrad Med J; 1979; 55 Suppl 5():90-4. PubMed ID: 395527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of prostatic carcinoma by gonadotropin inhibition with danazol. A preliminary report.
    Freedman DL; Carlström K; Esposti PL; Hedlund PO
    Scand J Urol Nephrol Suppl; 1980; 55():173-5. PubMed ID: 6782665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized placebo- and active-controlled study of desvenlafaxine for menopausal vasomotor symptoms.
    Bouchard P; Panay N; de Villiers TJ; Vincendon P; Bao W; Cheng RJ; Constantine G
    Climacteric; 2012 Feb; 15(1):12-20. PubMed ID: 22066790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Danazol therapy in gynaecomastia; recent experience and indications for therapy.
    Buckle R
    Postgrad Med J; 1979; 55 Suppl 5():71-8. PubMed ID: 537953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurokinin 3 Receptor Antagonism Reveals Roles for Neurokinin B in the Regulation of Gonadotropin Secretion and Hot Flashes in Postmenopausal Women.
    Skorupskaite K; George JT; Veldhuis JD; Millar RP; Anderson RA
    Neuroendocrinology; 2018; 106(2):148-157. PubMed ID: 28380486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of naloxone on hot flashes and gonadotropin secretion in postmenopausal women.
    DeFazio J; Verheugen C; Chetkowski R; Nass T; Judd HL; Meldrum DR
    J Clin Endocrinol Metab; 1984 Mar; 58(3):578-81. PubMed ID: 6420445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormone binding globulin levels in patients with hereditary angiooedema during treatment with Danazol.
    Schwarz S; Tappeiner G; Hintner H
    Clin Endocrinol (Oxf); 1981 Jun; 14(6):563-70. PubMed ID: 6794961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desvenlafaxine compared with placebo for treatment of menopausal vasomotor symptoms: a 12-week, multicenter, parallel-group, randomized, double-blind, placebo-controlled efficacy trial.
    Pinkerton JV; Constantine G; Hwang E; Cheng RF;
    Menopause; 2013 Jan; 20(1):28-37. PubMed ID: 23010882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Controlled trial of the antigonadotropin danazol in painful nodular benign breast disease.
    Mansel RE; Wisbey JR; Hughes LE
    Lancet; 1982 Apr; 1(8278):928-30. PubMed ID: 6122770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural and functional regression of polycystic ovaries by danazol.
    Raj SG; Raj MH; Talbert LM; Dy RC
    Fertil Steril; 1981 Sep; 36(3):392-5. PubMed ID: 7197232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal, metabolic and clinical effects of danazol in the treatment of endometriosis.
    Rannevik G
    Postgrad Med J; 1979; 55 Suppl 5():14-20. PubMed ID: 537948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical effects of danazol on endometrial hyperplasia in menopausal and postmenopausal women.
    Soh E; Sato K
    Cancer; 1990 Sep; 66(5):983-8. PubMed ID: 2386926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Danazol treatment of chronic cystic mastopathy: a clinical and hormonal evaluation.
    Dhont M; Delbeke L; van Eyck J; Voorhoof L
    Postgrad Med J; 1979; 55 Suppl 5():66-70. PubMed ID: 395523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of acupuncture on hot flashes in perimenopausal and postmenopausal women--a multicenter randomized clinical trial.
    Kim KH; Kang KW; Kim DI; Kim HJ; Yoon HM; Lee JM; Jeong JC; Lee MS; Jung HJ; Choi SM
    Menopause; 2010 Mar; 17(2):269-80. PubMed ID: 19907348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.